Last Updated: 17 Oct 2024
Executive Summary
NewGenIvf Group Limited (NIVF) is a healthcare company that provides fertility treatments and services. The company has a market capitalization of $7.09 million and trades on the NASDAQ exchange. NIVF's latest stock price is $1.22.
The company's financial performance has been mixed in recent quarters. Revenue has declined in recent quarters, and the company has reported losses in each of the past four quarters. However, the company's gross profit margin has improved in recent quarters.
Technically, NIVF is in a downtrend. The stock price has been making lower lows and lower highs since early 2023. The stock is currently trading below its 50-day and 200-day moving averages.
Company Overview
NewGenIvf Group Limited is a healthcare company that provides fertility treatments and services. The company operates a network of fertility clinics in Thailand, Malaysia, and Singapore. NIVF offers a range of fertility treatments, including IVF, ICSI, and surrogacy.
The company was founded in 2008 and is headquartered in Bangkok, Thailand. NIVF is a publicly traded company and its shares are listed on the NASDAQ exchange.
Fundamental Analysis
NIVF's financial performance has been mixed in recent quarters. Revenue has declined in recent quarters, and the company has reported losses in each of the past four quarters. However, the company's gross profit margin has improved in recent quarters.
In the most recent quarter, NIVF reported revenue of $0 million, down from $0 million in the same quarter last year. The company reported a net loss of $0 million, compared to a net loss of $0 million in the same quarter last year.
NIVF's gross profit margin improved to 0% in the most recent quarter, up from 0% in the same quarter last year. The company's operating expenses increased in the most recent quarter, driven by higher marketing and administrative expenses.
Technical Analysis
Technically, NIVF is in a downtrend. The stock price has been making lower lows and lower highs since early 2023. The stock is currently trading below its 50-day and 200-day moving averages.
The relative strength index (RSI) is currently at 30.36, which indicates that the stock is oversold. The moving average convergence divergence (MACD) is currently below the signal line, which indicates that the stock is in a downtrend.
Short Term Outlook
The short-term outlook for NIVF is negative. The stock price is in a downtrend and the technical indicators are bearish. The stock is likely to continue to decline in the short term.
Long Term Outlook
The long-term outlook for NIVF is uncertain. The company's financial performance has been mixed in recent quarters and the stock price is in a downtrend. However, the company's gross profit margin has improved in recent quarters and the stock is oversold. The stock could rebound in the long term if the company can improve its financial performance.
Analyst Recommendations
Analysts are mixed on NIVF. Some analysts believe that the stock is undervalued and has a lot of upside potential. Other analysts believe that the stock is overvalued and is likely to continue to decline.
Overall, the analyst consensus on NIVF is neutral.
